News + Filings Transactions
|
McLaughlin Gerald W.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 04/08/2021 | AYTU BIOPHARMA, INC | AYTU | Grant | Common Stock | 6.5k | $0.00 | $0 | | 04/08/2021 |
| 03/19/2021 | Neos Therapeutics, Inc. | NEOS | Disposition | Common Stock | 270.2k | $0.00 | $0 | | 03/19/2021 |
| 03/19/2021 | Neos Therapeutics, Inc. | NEOS | Disposition | Stock Option (Right to Buy) | 600k | $6.20 | $3.7M | | 03/19/2021 |
| 03/19/2021 | Neos Therapeutics, Inc. | NEOS | Disposition | Stock Option (Right to Buy) | 392.7k | $2.31 | $907.1k | | 03/19/2021 |
| 03/19/2021 | Neos Therapeutics, Inc. | NEOS | Disposition | Stock Option (Right to Buy) | 395k | $1.49 | $588.6k | | 03/19/2021 |
| 03/19/2021 | Neos Therapeutics, Inc. | NEOS | Disposition | Stock Option (Right to Buy) | 100k | $5.55 | $555k | | 03/19/2021 |
| 03/19/2021 | Neos Therapeutics, Inc. | NEOS | Disposition | Stock Option (Right to Buy) | 65.4k | $2.31 | $151.2k | | 03/19/2021 |
| 03/02/2021 | Neos Therapeutics, Inc. | NEOS | Payment of Exercise | Common Stock | 44.3k | $0.84 | $37.4k | | 03/02/2021 |
| 03/13/2020 | Neos Therapeutics, Inc. | NEOS | Grant | Stock Option (Right to Buy) | 65.4k | $2.31 | $151.2k | | 03/13/2020 |
| 03/13/2020 | Neos Therapeutics, Inc. | NEOS | Grant | Stock Option (Right to Buy) | 100k | $5.55 | $555k | | 03/13/2020 |
| 03/02/2020 | Neos Therapeutics, Inc. | NEOS | Grant | | 290k | $0.00 | $0 | | 03/02/2020 |
| 03/02/2020 | Neos Therapeutics, Inc. | NEOS | Grant | Stock Option (Right to Buy) | 395k | $1.49 | $588.6k | | 03/02/2020 |
| 03/01/2019 | Neos Therapeutics, Inc. | NEOS | Grant | Stock Option (Right to Buy) | 392.7k | $2.31 | $907.1k | | 03/01/2019 |
| 03/01/2019 | Neos Therapeutics, Inc. | NEOS | Grant | Stock Option (Right to Buy) | 523.6k | $2.31 | $1.2M | | 03/01/2019 |
| 12/06/2018 | Neos Therapeutics, Inc. | NEOS | Purchase | Common Stock | 17.1k | $2.11 | $36.1k | | 12/06/2018 |
| 12/04/2018 | Neos Therapeutics, Inc. | NEOS | Purchase | Common Stock | 7.4k | $2.04 | $15.1k | | 12/04/2018 |
| 06/27/2018 | Neos Therapeutics, Inc. | NEOS | Grant | Stock Option (Right to Buy) | 600k | $6.20 | $3.7M | | 06/27/2018 |
| 10/20/2015 | Skye Bioscience, Inc. | NMUS | Grant | | 30k | $0.00 | $0 | | 10/20/2015 |
| 08/20/2015 | Skye Bioscience, Inc. | NMUS | Conversion | Series A Preferred Stock | 10k | $0.00 | $0 | | 08/20/2015 |
| 08/20/2015 | Skye Bioscience, Inc. | NMUS | Conversion | Common Stock | 31.2k | $0.00 | $0 | | 08/20/2015 |
| 05/29/2015 | Skye Bioscience, Inc. | NMUS | Purchase | | 2k | $5.00 | $10k | | 05/29/2015 |
| 05/29/2015 | Skye Bioscience, Inc. | NMUS | Purchase | | 10k | $2.50 | $25k | | 05/29/2015 |
| 12/04/2014 | Skye Bioscience, Inc. | NMUS | Grant | Stock Option (Right to Buy) | 20k | $0.00 | $0 | | 12/04/2014 |
| 01/17/2013 | NUPATHE INC. | PATH | Grant | | 125k | $0.00 | $0 | | 01/17/2013 |
| 01/07/2013 | NUPATHE INC. | PATH | Disposition | Stock Option (Right to Buy) | 32.8k | $3.06 | $100.5k | | 01/07/2013 |
| 01/07/2013 | NUPATHE INC. | PATH | Disposition | Stock Option (Right to Buy) | 16.2k | $10.00 | $162.2k | | 01/07/2013 |
| 01/07/2013 | NUPATHE INC. | PATH | Grant | | 23.5k | $0.00 | $0 | | 01/07/2013 |
| 01/07/2013 | NUPATHE INC. | PATH | Grant | | 8.1k | $0.00 | $0 | | 01/07/2013 |
| 03/08/2012 | NUPATHE INC. | PATH | Grant | Stock Option (Right to Buy) | 32.8k | $3.06 | $100.5k | | 03/08/2012 |
|